Chemoinformaics analysis of 2-Methylallyl 2-methylisocrotonate
Molecular Weight | 154.209 | nRot | 3 |
Heavy Atom Molecular Weight | 140.097 | nRig | 3 |
Exact Molecular Weight | 154.099 | nRing | 0 |
Solubility: LogS | -1.75 | nHRing | 0 |
Solubility: LogP | 2.182 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 25.9691 |
nHD | 0 | BPOL | 16.6489 |
QED | 0.353 |
Synth | 2.73 |
Natural Product Likeliness | 1.491 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.264 |
MDCK | 0.0000326 |
BBB | 0.978 |
PPB | 0.627242 |
VDSS | 1.668 |
FU | 0.595932 |
CYP1A2-inh | 0.839 |
CYP1A2-sub | 0.727 |
CYP2c19-inh | 0.669 |
CYP2c19-sub | 0.828 |
CYP2c9-inh | 0.146 |
CYP2c9-sub | 0.261 |
CYP2d6-inh | 0.167 |
CYP2d6-sub | 0.297 |
CYP3a4-inh | 0.046 |
CYP3a4-sub | 0.276 |
CL | 10.853 |
T12 | 0.86 |
hERG | 0.013 |
Ames | 0.875 |
ROA | 0.048 |
SkinSen | 0.734 |
Carcinogencity | 0.786 |
EI | 0.993 |
Respiratory | 0.695 |
NR-Aromatase | 0.012 |
Antiviral | No |
Prediction | 0.941672 |